Showing results (1611-1620 of 1,744) with videos related to
Sort By:
Pageof 175
Heart Failure Reviews|July 10, 2021
Unveiling the role of exercise training in targeting the inflammatory paradigm of heart failure with preserved ejection fraction: a narrative reviewEliane Jaconiano, Daniel Moreira-GonçalvesHeart Failure Reviews|May 14, 2022
Endomyocardial biopsy in the clinical context: current indications and challenging scenariosAldostefano Porcari, Chiara Baggio, Enrico Fabris, et al.Heart Failure Reviews|July 28, 2021
Subclinical cardiac damage in cancer patients before chemotherapyIacopo Fabiani, Giorgia Panichella, Alberto Aimo, et al.Heart Failure Reviews|July 27, 2021
Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseasesMieczysław Dutka, Rafał Bobiński, Wojciech Wojakowski, et al.Heart Failure Reviews|July 17, 2021
Current and emerging drug targets in heart failure treatmentNicolò Ghionzoli, Francesco Gentile, Anna Maria Del Franco, et al.Heart Failure Reviews|May 19, 2022
Primary prevention implantable cardioverter-defibrillator use in non-ischemic dilated cardiomyopathy based on arrhythmic risk stratification and left ventricular reverse remodeling predictionAhmed Muhammed, Mohamed Abdelazeem, Mohamed Gamaleldin Elewa, et al.Heart Failure Reviews|May 19, 2022
Ambulatory factors influencing pulmonary artery pressure waveforms and implications for clinical practiceAmit Alam, Rita Jermyn, Ioannis Mastoris, et al.Heart Failure Reviews|May 20, 2022
Outcomes of heart transplantation in cardiac amyloidosis: an updated systematic reviewSofia Lakhdar, Chandan Buttar, Mahmood Nassar, et al.Heart Failure Reviews|May 21, 2022
Cardiac rehabilitation in heart failure with severely reduced ejection fraction: effects on mortalityNegin Sadat Hosseini Mohammadi, Mohammad Hasan Shaki Katouli, Farzad Masoudkabir, et al.Heart Failure Reviews|April 26, 2008
Beta-blocker pharmacogenetics in heart failureJaekyu Shin, Julie A JohnsonPageof 175